Page last updated: 2024-11-08

aspartic acid and Supranuclear Palsy, Progressive

aspartic acid has been researched along with Supranuclear Palsy, Progressive in 8 studies

Aspartic Acid: One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.
aspartic acid : An alpha-amino acid that consists of succinic acid bearing a single alpha-amino substituent
L-aspartic acid : The L-enantiomer of aspartic acid.

Supranuclear Palsy, Progressive: A degenerative disease of the central nervous system characterized by balance difficulties; OCULAR MOTILITY DISORDERS (supranuclear ophthalmoplegia); DYSARTHRIA; swallowing difficulties; and axial DYSTONIA. Onset is usually in the fifth decade and disease progression occurs over several years. Pathologic findings include neurofibrillary degeneration and neuronal loss in the dorsal MESENCEPHALON; SUBTHALAMIC NUCLEUS; RED NUCLEUS; pallidum; dentate nucleus; and vestibular nuclei. (From Adams et al., Principles of Neurology, 6th ed, pp1076-7)

Research Excerpts

ExcerptRelevanceReference
"As lesions associated with Guadeloupean parkinsonism are poorly characterized, it is not known to what extent they differ from progressive supranuclear palsy."1.36Magnetic resonance imaging lesion pattern in Guadeloupean parkinsonism is distinct from progressive supranuclear palsy. ( Bienaimée, MJ; Delmaire, C; Galanaud, D; Gaymard, B; Hartmann, A; Jodoin, N; Lannuzel, A; Lehéricy, S; Roze, E; Vidailhet, M, 2010)
"The study included 12 patients with progressive supranuclear palsy, 10 with Parkinson's disease, nine with corticobasal degeneration and 11 age-matched normal control subjects."1.30Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration. ( Bertolino, A; Bonavita, S; Hallett, M; Litvan, I; Lundbom, N; Patronas, NJ; Tedeschi, G, 1997)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (62.50)18.2507
2000's1 (12.50)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guevara, CA1
Blain, CR1
Stahl, D1
Lythgoe, DJ1
Leigh, PN1
Barker, GJ2
Lehéricy, S1
Hartmann, A1
Lannuzel, A1
Galanaud, D1
Delmaire, C1
Bienaimée, MJ1
Jodoin, N1
Roze, E1
Gaymard, B1
Vidailhet, M1
Guillozet-Bongaarts, AL1
Glajch, KE1
Libson, EG1
Cahill, ME1
Bigio, E1
Berry, RW1
Binder, LI1
Federico, F3
Simone, IL3
Lucivero, V3
De Mari, M3
Giannini, P2
Iliceto, G2
Mezzapesa, DM3
Lamberti, P3
Tedeschi, G1
Litvan, I1
Bonavita, S1
Bertolino, A1
Lundbom, N1
Patronas, NJ1
Hallett, M1
Davie, CA1
Machado, C1
Miller, DH1
Lees, AJ1
Tarantino, A1
Petruzzellis, M1
Ferrari, E1

Trials

1 trial available for aspartic acid and Supranuclear Palsy, Progressive

ArticleYear
Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy.
    Journal of neurology, neurosurgery, and psychiatry, 1997, Volume: 62, Issue:3

    Topics: Aged; Aspartic Acid; Corpus Striatum; Creatine; Globus Pallidus; Humans; Magnetic Resonance Spectros

1997

Other Studies

7 other studies available for aspartic acid and Supranuclear Palsy, Progressive

ArticleYear
Quantitative magnetic resonance spectroscopic imaging in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    European journal of neurology, 2010, Volume: 17, Issue:9

    Topics: Aged; Aspartic Acid; Basal Ganglia Diseases; Biomarkers; Female; Humans; Image Processing, Computer-

2010
Magnetic resonance imaging lesion pattern in Guadeloupean parkinsonism is distinct from progressive supranuclear palsy.
    Brain : a journal of neurology, 2010, Volume: 133, Issue:Pt 8

    Topics: Aged; Aspartic Acid; Brain; Case-Control Studies; Cognition Disorders; Creatinine; Diagnosis, Differ

2010
Phosphorylation and cleavage of tau in non-AD tauopathies.
    Acta neuropathologica, 2007, Volume: 113, Issue:5

    Topics: Aged; Aged, 80 and over; Aspartic Acid; Astrocytes; Basal Ganglia Diseases; Female; Humans; Immunohi

2007
Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration.
    Brain : a journal of neurology, 1997, Volume: 120 ( Pt 9)

    Topics: Aged; Aged, 80 and over; Aspartic Acid; Brain; Brain Diseases; Choline; Creatine; Female; Humans; Ma

1997
Proton magnetic resonance spectroscopy in Steele-Richardson-Olszewski syndrome.
    Movement disorders : official journal of the Movement Disorder Society, 1997, Volume: 12, Issue:5

    Topics: Adult; Aged; Aspartic Acid; Basal Ganglia; Case-Control Studies; Choline; Creatine; Diagnosis, Diffe

1997
Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders.
    Movement disorders : official journal of the Movement Disorder Society, 1997, Volume: 12, Issue:6

    Topics: Aged; Antiparkinson Agents; Aspartic Acid; Atrophy; Cerebral Cortex; Choline; Corpus Striatum; Creat

1997
Usefulness of proton magnetic resonance spectroscopy in differentiating parkinsonian syndromes.
    Italian journal of neurological sciences, 1999, Volume: 20, Issue:4

    Topics: Adult; Aged; Aspartic Acid; Brain; Choline; Creatine; Diagnosis, Differential; Disease Progression;

1999